About Asston Pharmaceuticals Ltd
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc.
Founded
2019
CEO
Saili Jayaram More
Employees
0
HQ
Mumbai, Maharashtra
Finished Products
1Sale of Products
₹39.30Cr2Sale of Services
₹1.32CrRaw Materials
1Material Consumed
₹22.42CrAbout Asston Pharmaceuticals Ltd
Asston Pharmaceuticals is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African and Asian markets. Presently our Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion), and Oral Powder (Sachet, Dry Syrup) etc.
Founded:2019
CEO:Saili Jayaram More
Employees:0
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Products
₹39.30Cr2Sale of Services
₹1.32CrRaw Materials
1Material Consumed
₹22.42CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹126
52W Low
₹60
Volume12.00K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
23.82x
Valuation
P/B Ratio
2.37x
Valuation
EPS
₹4.54
Valuation
Dividend Yield
0.00%
Valuation
ROE
9.95%
Profitability
ROCE
11.89%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing and Selling of PharmaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
13.8%
International
86.2%
Export86.2%
Domestic13.8%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.13x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
56.4%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.